American International Group, Inc. Nuvectis Pharma, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.69 - $11.0 $207 - $341	-31 Reduced 0.84%	3,664 $30,000
Q4 2023 Feb 13, 2024	SELL	$7.85 - $11.78 $125 - $188	-16 Reduced 0.43%	3,695 $30,000
Q3 2023 Nov 13, 2023	BUY	$12.89 - $16.29 $5,323 - $6,727	413 Added 12.52%	3,711 $47,000
Q2 2023 Aug 04, 2023	BUY	$12.62 - $18.4 $41,620 - $60,683	3,298 New	3,298 $52,000

1.65M

Ticker NVCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,642,500
Market Cap $68.8M
Description
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.